SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech informs about book closure

25 Aug 2022 Evaluate

Pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements), 2015, Windlas Biotech has informed that the Register of Members and Share Transfer Books of the Company will remain closed from 13th September 2022 to 19th September 2022 for the purpose of forthcoming Annual General Meeting of the Company scheduled to be held on Monday, the 19th September 2022, and the record date shall be 12th September, 2022, as per details enclosed.

The above information is a part of company’s filings submitted to BSE.


Windlas Biotech Share Price

865.40 -6.35 (-0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×